Mumbai based Pregna International Ltd has partnered with Dr Thomas Burke’s Vayu Global Health Initiative to introduce an economical solution to post-partum haemorrhage (PPH) – one of the leading causes of maternal mortality.

Dr Burke and his teams at the Massachusetts General Hospital, Harvard University and the Vayu Global Health Foundation have worked on developing studying an effective and inexpensive solution which is user friendly and can be used even in low-resource settings.

Dr Burke commented on this partnership – “We have been working on the UBT kit for the past 12 years and we are excited to partner with Pregna to make it available on a large scale to health workers all over the world.”

Speaking about the work, Ajit Raje, Vice President, Pregna stated, “While UBT is a great invention and is very useful in managing most cases of PPH, notably shown in the improvements in mortality rates in parts of Asia, most devices available in the market today are priced at a premium, which limits its effectiveness. Dr Burke and his team have broken the pricing barrier.”

Speaking about the partnership, Mukul Taparia, Managing Director, Pregna noted, “Pregna will bring its manufacturing, marketing & regulatory expertise to elevate its scalability and maximise its reach.”

Pregna expects to launch Dr Burke’s ESM-UBT kit in the second quarter of 2021. The product is US FDA certified and has undergone many trials.